VICENTE
ESTRADA PÉREZ
Profesor asociado de Ciencias de la Salud
Hospital Clínico San Carlos de Madrid
Madrid, EspañaPublications in collaboration with researchers from Hospital Clínico San Carlos de Madrid (140)
2024
-
Incidence of sexually transmitted infections and screening models among pre-exposure prophylaxis users
Enfermedades Infecciosas y Microbiologia Clinica
-
Monkeypox virus genomic accordion strategies
Nature Communications, Vol. 15, Núm. 1
-
Mpox, herpes, and enteroviruses: Differential diagnosis
Journal of Medical Virology
2023
-
Clinical outcomes by supplemental oxygen use in remdesivir-treated, hospitalised adults with COVID-19
Infectious Diseases Now, Vol. 53, Núm. 7
-
Differences in the inflammatory response among hospitalized patients with distinct variants of SARS-CoV-2
Frontiers in Immunology, Vol. 14
-
Monitoring monkeypox virus in saliva and air samples in Spain: a cross-sectional study
The Lancet Microbe, Vol. 4, Núm. 1, pp. e21-e28
-
Mortality reduction in older COVID-19-patients hospitalized in Spain during the second pandemic wave from the SEMI-COVID-19 Registry
Scientific Reports, Vol. 13, Núm. 1
-
Plitidepsin in adult patients with COVID-19 requiring hospital admission: A long-term follow-up analysis
Frontiers in Cellular and Infection Microbiology, Vol. 13
-
Specific Cellular and Humoral Immune Responses to the Neoantigen RBD of SARS-CoV-2 in Patients with Primary and Secondary Immunodeficiency and Healthy Donors
Biomedicines, Vol. 11, Núm. 4
-
Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens
The Journal of antimicrobial chemotherapy, Vol. 78, Núm. 11, pp. 2696-2701
-
TRPC6 inhibitor (BI 764198) to reduce risk and severity of ARDS due to COVID-19: a phase II randomised controlled trial
Thorax, Vol. 78, Núm. 8, pp. 816-824
-
Tenofovir Disoproxil Fumarate/Emtricitabine and Baricitinib for Patients at High Risk of Severe Coronavirus Disease 2019: The PANCOVID Randomized Clinical Trial
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 76, Núm. 3, pp. e116-e125
-
Use of Monoclonal Antibodies in Immunocompromised Patients Hospitalized with Severe COVID-19: A Retrospective Multicenter Cohort
Journal of Clinical Medicine, Vol. 12, Núm. 3
2022
-
Chronic Oral Anticoagulation Therapy and Prognosis of Patients Admitted to Hospital for COVID-19: Insights from the HOPE COVID-19 Registry
International Journal of Clinical Practice, Vol. 2022
-
Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57)
Open Forum Infectious Diseases
-
Discovering HIV related information by means of association rules and machine learning
Scientific Reports, Vol. 12, Núm. 1
-
Effect of EARLY administration of DEXamethasone in patients with COVID-19 pneumonia without acute hypoxemic respiratory failure and risk of development of acute respiratory distress syndrome (EARLY-DEX COVID-19): study protocol for a randomized controlled trial
Trials, Vol. 23, Núm. 1
-
Efficiency of screening for human immunodeficiency virus infection in emergency departments: a systematic review and meta-analysis
Emergencias, Vol. 34, Núm. 3, pp. 204-212
-
Epidemiologic and Economic Analysis of Rapid Antiretroviral Therapy Initiation with Bictegravir/Emtricitabine/Tenofovir Alafenamide in Spain
PharmacoEconomics - Open, Vol. 6, Núm. 3, pp. 415-424
-
Epidemiological trends of HIV/HCV coinfection in Spain, 2015–2019
HIV Medicine, Vol. 23, Núm. 7, pp. 705-716